Clinical Trials in Cáceres, Extremadura
8 recruiting
Showing 1–8 of 8 trials
Recruiting
Phase 3
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
Cardiovascular Disease and Lipoprotein(a)
Novartis Pharmaceuticals5,700 enrolled492 locationsNCT07517263
Recruiting
Phase 1Phase 2
Study of ART6043 in Advanced/Metastatic Solid Tumors Patients (POLKA)
Advanced Solid TumorMetastatic Solid Tumor
Artios Pharma Ltd181 enrolled12 locationsNCT05898399
Recruiting
Phase 2
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis
Aortic Stenosis
Novartis Pharmaceuticals502 enrolled139 locationsNCT05646381
Recruiting
Observational Study of the Effectiveness of Funded Drugs for Genitourinary Tumors.
Genitourinary Cancers
Spanish Oncology Genito-Urinary Group500 enrolled84 locationsNCT06724159
Recruiting
Phase 2
A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD
Chronic Obstructive Pulmonary Disease
Upstream Bio Inc.666 enrolled325 locationsNCT06981078
Recruiting
Phase 2
Response-adaptive to Epcoritamab In First Relapse: Study to Evaluate the Efficacy of Eptoritamab in Patients With Relapse/Refractory Large B Cell Lymphoma
Large B-cell Lymphoma
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea80 enrolled15 locationsNCT07126236
Recruiting
Descriptive Observational Study on the Characteristics of Advanced and Metastatic Melanoma in Spain
Advanced CancerMelanoma Stage IVMelanoma Stage III
Grupo Español Multidisciplinar de Melanoma400 enrolled39 locationsNCT03605771
Recruiting
Safety of IBD Drugs During Pregnancy and Breastfeeding: Mothers and Babies' Outcomes (DUMBO Registry)
PregnancyInflammatory Bowel Diseases
Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa1,750 enrolled73 locationsNCT03894228